Jun 22, 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Jun 03, 2020
NeoTract Designates Dr. Philippe Nabbout as UroLift® Center of Excellence
May 26, 2020
FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
May 21, 2020
NeoTract Designates Dr. Naveen Divakaruni as UroLift® Center of Excellence
May 20, 2020
NeoTract Designates Dr. Manuel Eisenberg as UroLift® Center of Excellence
May 13, 2020
NeoTract Designates Dr. Ali Sarram as UroLift® Center of Excellence
May 12, 2020
NeoTract Designates Dr. Marina Cheng as UroLift® Center of Excellence
May 07, 2020
NeoTract Designates Dr. Amar Raval as UroLift® Center of Excellence
May 06, 2020
NeoTract Designates Dr. Keith Waguespack as UroLift® Center of Excellence
May 05, 2020
NeoTract Designates Dr. Jorge Arzola as UroLift® Center of Excellence
May 04, 2020
NeoTract Designates Dr. Carl Bischoff as UroLift® Center of Excellence
Apr 29, 2020
NeoTract Designates Dr. Jay Page as UroLift® Center of Excellence
Apr 28, 2020
NeoTract Designates Dr. Peter Burrows as UroLift® Center of Excellence
Apr 23, 2020
NeoTract Designates Dr. Bayo Tojuola as UroLift® Center of Excellence
Apr 22, 2020
NeoTract Designates Dr. Koushik Shaw as UroLift® Center of Excellence
Apr 21, 2020
NeoTract Designates Dr. P. Sean Van Zijl as UroLift® Center of Excellence
Apr 20, 2020
NeoTract Designates Dr. Thomas Chun as UroLift® Center of Excellence
Apr 17, 2020
NeoTract Designates Dr. Andrew Davidiuk as UroLift® Center of Excellence
Apr 15, 2020
NeoTract Designates Dr. Timothy Goodson as UroLift® Center of Excellence
Apr 13, 2020
NeoTract Designates Dr. Andrew Wright as UroLift® Center of Excellence